The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Little Evidence Shows Cannabis Helps Chronic Pain or PTSD

Little Evidence Shows Cannabis Helps Chronic Pain or PTSD

August 16, 2017 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—Even though pain and posttraumatic stress disorder (PTSD) are among the most common reasons people use medical marijuana in the U.S., there isn’t much proof cannabis works for either one of these conditions, two research reviews suggest.

You Might Also Like
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Teva Pharm to Market Medical Cannabis Inhaler in Israel
  • Evidence Needed to Support Marijuana Use for Pain Relief in Rheumatologic Conditions

That’s because there hasn’t been enough high-quality research to produce conclusive evidence of the benefits or harms of cannabis for pain or PTSD, the two studies found. Both studies were conducted by a team of researchers at the Veterans Health Administration and published in Annals of Internal Medicine, online Aug. 14.1,2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The current studies highlight the real and urgent need for high-quality clinical trials in both of these areas,” says Dr. Sachin Patel, a psychiatry researcher at Vanderbilt University Medical Center in Nashville.

“If cannabis is being considered for medical use, it should certainly be after all well-established treatments have failed,” Patel says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One in 10 U.S. adults use cannabis, the researchers note. Medical marijuana is legal in 28 states and the District of Columbia, but it remains illegal under federal law.

Between 45% and 85% of people seeking medical marijuana in the U.S. do so for pain management, according to the researchers. But when they examined 27 previously published studies on this topic, they found too little information to determine whether the drug helps most types of pain.

They found only low-quality evidence that cannabis may help nerve pain, and this wasn’t for smoking pot, it was for nabiximols, oral mixtures that are sprayed into the mouth.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A separate analysis of five previous studies of cannabis for PTSD found too little data to determine whether this would help relieve symptoms.

One of the studies in the analysis focused on veterans with PTSD and found a small but statistically significant decline in symptoms for patients who started using cannabis, however, compared with people who never tried it or quit.

Among the general population, not just people with pain or PTSD, the researchers concluded cannabis may carry harms including an increased risk of car crashes, psychotic episodes and cognitive impairments.

Both studies were commissioned and funded by the Veterans Health Administration.

Curt Cashour, press secretary for the Department of Veterans Affairs, declined to make the lead study authors available for comment on their research.

In a statement about cannabis earlier this year, Dr. David Shulkin, Secretary of Veterans Affairs, says, “There may be some evidence that this is beginning to be helpful.”3

“And we’re interested in looking at that and learning from that,” Shulkin said in the May 2017 statement. “But until the time that federal law changes, we are not able to be able to prescribe medical marijuana for conditions that may be helpful.”

Pages: 1 2 | Single Page

Filed Under: Analgesics, Drug Updates Tagged With: cannabis, Chronic pain, medical marijuana, Pain, Pain Management, Post-Traumatic Stress Disorder (PTSD)

You Might Also Like:
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Teva Pharm to Market Medical Cannabis Inhaler in Israel
  • Evidence Needed to Support Marijuana Use for Pain Relief in Rheumatologic Conditions
  • Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)